Intellectual property protection: strategies for antibody inventions.

Abstract

In the last decade, therapeutic antibodies have become one of the commercially most successful classes of biopharmaceutical drugs. Major drug manufacturers who have successfully managed to occupy this new market, as well as biotechnology firms, some of which have experienced a quick growth and are now on par with the former, owe part of their success to… (More)

Topics

  • Presentations referencing similar topics